ArticleMaedica2016
Thrombocytopenia in Pregnancy.
Article in Maedica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.
- Preeclampsia has an association with both platelet count and mean platelet volume: A systematic review and meta-analysis.PloS one · 2022Pooled it
- Thrombocytopenia in Pregnancy: Clinical Challenges, Maternal-Fetal Risks, and Management Strategies.Life (Basel, Switzerland) · 2026Review
- Pregnancy-Associated Thrombotic Thrombocytopenic Purpura: Diagnostic Pitfalls, Therapeutic Strategies, and Emerging Paradigms.Biomedicines · 2026Review
- Diagnostic and prognostic role of platelet indices in pre-eclampsia: Insights from a hospital-based study in Eastern part of India.Journal of education and health promotion · 2026Article
- Physiological Changes and Trimester-Specific Reference Intervals for Complete Blood Count Parameters in Korean Pregnant Women.Medicina (Kaunas, Lithuania) · 2025Article
- Pregnancy and postpartum dynamics revealed by millions of lab tests.Science advances · 2025Article
- Use and Effects of Eltrombopag in Pregnant Woman With Difficult-to-Treat Idiopathic Thrombocytopenic Purpura (ITP).Case reports in hematology · 2025Article
- ITP in pregnancy: diagnostics and therapeutics in 2024.Hematology. American Society of Hematology. Education Program · 2024Review
- Prevalence of Thrombocytopenia in Pregnant Women with COVID-19: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2024Review
- Review
- Review
- Article
- Thrombocytopaenia and COVID-19 infection during pregnancy increases the risk of preeclampsia: a multicentre study.Reproductive biomedicine online · 2023Article
- Dengue in Pregnancy: A Southeast Asian Perspective.Tropical medicine and infectious disease · 2023Review
- Recurrent Gestational Thrombocytopenia Affecting Four Consecutive Pregnancies: A Case Report.Cureus · 2023Article
- Analysis of cellular and cell free mitochondrial DNA content and reactive oxygen species levels in maternal blood during normal pregnancy: a pilot study.BMC pregnancy and childbirth · 2022Article
- An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics.Journal of basic and clinical physiology and pharmacology · 2022Review
- Thrombocytopenia Among Pregnant Women in Southwest Ethiopia: Burden, Severity, and Predictors.Journal of blood medicine · 2022Article
- Correlation of platelet parameters with adverse maternal and neonatal outcomes in severe preeclampsia: A case-control study.Heliyon · 2021Article
- Vascular Dysfunction in Preeclampsia.Cells · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombocytopenia, defined as blood platelet count below 150,000/ìL is the second leading cause of blood disorders in pregnancy after anemia. Gestational thrombocytopenia explains 70-80% of all cases of thrombocytopenia in pregnancy. Hypertensive disorders account for approximately 20% and immune thrombocytopenic purpura for about 3-4%. Other etiologies are considered rare in pregnancy. The aim of this study is to review the specific causes of thrombocytopenia in pregnancy, their obstetrical implications and management.
Identifiers
28465752PMC5394486W3025576313What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.